Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

How logically impossible patents block biosimilars.

Price WN 2nd, Rai AK.

Nat Biotechnol. 2019 Aug;37(8):862-863. doi: 10.1038/s41587-019-0196-x. No abstract available.

PMID:
31375793
2.

Shadow health records meet new data privacy laws.

Price WN 2nd, Kaminski ME, Minssen T, Spector-Bagdady K.

Science. 2019 Feb 1;363(6426):448-450. doi: 10.1126/science.aav5133. No abstract available.

3.

Privacy in the age of medical big data.

Price WN 2nd, Cohen IG.

Nat Med. 2019 Jan;25(1):37-43. doi: 10.1038/s41591-018-0272-7. Epub 2019 Jan 7. Review.

PMID:
30617331
4.

Big data and black-box medical algorithms.

Price WN.

Sci Transl Med. 2018 Dec 12;10(471). pii: eaao5333. doi: 10.1126/scitranslmed.aao5333. Review.

PMID:
30541791
5.

Regulating Black-Box Medicine.

Price WN II.

Mich Law Rev. 2017;116(3):421-74.

PMID:
29240330
6.

Promoting healthcare innovation on the demand side.

Eisenberg RS, Price WN 2nd.

J Law Biosci. 2017 Jan 16;4(1):3-49. doi: 10.1093/jlb/lsw062. eCollection 2017 Apr.

7.

The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases.

Klonoff DC, Price WN 2nd.

J Diabetes Sci Technol. 2017 Mar;11(2):220-223. doi: 10.1177/1932296816680006. Epub 2016 Dec 5.

8.

Codon influence on protein expression in E. coli correlates with mRNA levels.

Boël G, Letso R, Neely H, Price WN, Wong KH, Su M, Luff J, Valecha M, Everett JK, Acton TB, Xiao R, Montelione GT, Aalberts DP, Hunt JF.

Nature. 2016 Jan 21;529(7586):358-363. doi: 10.1038/nature16509. Epub 2016 Jan 13.

9.

Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

Price WN 2nd, Minssen T.

Nat Biotechnol. 2015 Jul;33(7):685-6. doi: 10.1038/nbt.3243. No abstract available.

PMID:
26154001
10.

Drug Development. Are trade secrets delaying biosimilars?

Price WN 2nd, Rai AK.

Science. 2015 Apr 10;348(6231):188-9. doi: 10.1126/science.aab1684. Epub 2015 Apr 9. No abstract available.

PMID:
25859034
11.

The authors reply.

Appelbaum PS, Chung W, Fyer AJ, Klitzman RL, Martinez J, Parens E, Price WN, Waldman C.

Hastings Cent Rep. 2015 Jan-Feb;45(1):4. doi: 10.1002/hast.408. No abstract available.

PMID:
25600379
12.

Models of consent to return of incidental findings in genomic research.

Appelbaum PS, Parens E, Waldman CR, Klitzman R, Fyer A, Martinez J, Price WN 2nd, Chung WK.

Hastings Cent Rep. 2014 Jul-Aug;44(4):22-32. doi: 10.1002/hast.328. Epub 2014 Jun 11.

13.

Informed consent for return of incidental findings in genomic research.

Appelbaum PS, Waldman CR, Fyer A, Klitzman R, Parens E, Martinez J, Price WN 2nd, Chung WK.

Genet Med. 2014 May;16(5):367-73. doi: 10.1038/gim.2013.145. Epub 2013 Oct 24.

14.

Legal implications of an ethical duty to search for genetic incidental findings.

Price WN 2nd.

Am J Bioeth. 2013;13(2):48-9. doi: 10.1080/15265161.2012.754068. No abstract available.

PMID:
23391063
15.

Large-scale experimental studies show unexpected amino acid effects on protein expression and solubility in vivo in E. coli.

Price WN 2nd, Handelman SK, Everett JK, Tong SN, Bracic A, Luff JD, Naumov V, Acton T, Manor P, Xiao R, Rost B, Montelione GT, Hunt JF.

Microb Inform Exp. 2011 Jun 27;1(1):6. doi: 10.1186/2042-5783-1-6.

16.

Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data.

Price WN 2nd, Chen Y, Handelman SK, Neely H, Manor P, Karlin R, Nair R, Liu J, Baran M, Everett J, Tong SN, Forouhar F, Swaminathan SS, Acton T, Xiao R, Luft JR, Lauricella A, DeTitta GT, Rost B, Montelione GT, Hunt JF.

Nat Biotechnol. 2009 Jan;27(1):51-7. doi: 10.1038/nbt.1514.

17.

AN EPIDEMIC OF ERYTHEMA MULTIFORME AND ERYTHEMA NODOSUM CAUSED BY HISTOPLASMOSIS.

SELLERS TF Jr, PRICE WN Jr, NEWBERRY WM Jr.

Ann Intern Med. 1965 Jun;62:1244-62. No abstract available.

PMID:
14295506

Supplemental Content

Loading ...
Support Center